Chronic Heart Failure Clinical Practice Guidelines’ Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?

por Abarquez, Ramon F., Reganit, Paul Ferdinand M., Chungunco, Carmen N., Alcover, Jean, Punzalan, Felix Eduardo R., Reyes, Eugenio B., Cunanan, Elleen L.
Publicado 2016

The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE Heart Failure Care network()()

por Cowie, Martin R., Mourilhe-Rocha, Ricardo, Chang, Hung-Yu, Volterrani, Maurizio, Ban, Ha Ngoc, Campos de Albuquerque, Denilson, Chung, Edward, Fonseca, Cândida, Lopatin, Yuri, Magaña Serrano, José Antonio, Mircheva, Lilyana, Moncada-Paz, Gustavo Adolfo, Pagava, Zurab, Reyes, Eugenio B., Saldarriaga, Clara, Schwartzmann, Pedro, Sim Kheng Leng, David, Trivi, Marcelo, Yotov, Yoto Trifonov, Zieroth, Shelley
Publicado 2022

Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes

por Tan, Jack Wei Chieh, Sim, David, Ako, Junya, Almahmeed, Wael, Cooper, Mark E, Dalal, Jamshed J, Deerochanawong, Chaicharn, Huang, David Wei Chun, Johar, Sofian, Kaul, Upendra, Kim, Sin Gon, Koh, Natalie, Kong, Alice Pik-Shan, Krittayaphong, Rungroj, Kwok, Bernard, Matawaran, Bien J, Nguyen, Quang Ngoc, Ong, Loke Meng, Park, Jin Joo, Peng, Yongde, Quek, David KL, Suastika, Ketut, Sukor, Norlela, Teo, Boon Wee, Teoh, Chee Kiang, Zhang, Jian, Reyes, Eugenio B, Goh, Su Yen
Publicado 2021